Sona Announces Ethics Committee Approval For Melanoma Clinical Trial
Go back to Sona Announces Ethics Committee Approval For Melanoma Clinical Trial| (AMEX: SNANF) | Delayed: 0.28 +0.03 (12.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.25 | 52 Week High | $ | |||
| Open | $0.28 | 52 Week Low | $ | |||
| Day High | $0.28 | P/E | N/A | |||
| Day Low | $0.28 | EPS | $ | |||
| Volume | 2,000 | |||||

